European Heart Journal Advance Access originally published online on November 7, 2006
European Heart Journal 2007 28(5):575-580; doi:10.1093/eurheartj/ehl355
Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system?
1 Department of Clinical Genetics, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
2 Department of Cardiology, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
3 Department of Clinical Epidemiology, Biostatistics, and Bioinformatics, Academic Medical Center, University of Amsterdam, Meibergdreef 9, 1105 AZ Amsterdam, The Netherlands
4 Department of Cardiology, Ludwig-Maximilians University, Klinikum Grosshadern, München, Germany
Received 8 May 2006; revised 4 October 2006; accepted 13 October 2006; online publish-ahead-of-print 7 November 2006.
* Corresponding author. Tel: +31 20 5663264; fax: +31 20 6975458. E-mail address: h.l.tan{at}amc.uva.nl
See page 527 for the editorial comment on this article (doi:10.1093/eurheartj/ehl552)
Aims Previously published diagnostic systems, based on ECG analysis and clinical parameters (Schwartz criteria and Keating criteria), have been used to estimate the probability of inherited long QT syndrome (LQTS). Nowadays, a certain diagnosis can often be made by DNA testing. We aimed to establish the predictive power of the Schwartz and Keating criteria, using DNA testing as a reference, and to determine the best diagnostic strategy.
Methods and results We studied 513 relatives (aged >10 years) of 77 consecutive LQTS probands with a known disease-causing mutation. The Schwartz criteria identified high probability of LQTS (score
4) in 41 of 208 mutation carriers, yielding 19% sensitivity and 99% specificity. The Keating criteria had 36% sensitivity and 99% specificity. Alternatively, by analysing QTc duration alone, we found that 430 ms is the optimal cut-off value to distinguish carriers (
430 ms) from non-carriers (<430 ms), yielding 72% sensitivity and 86% specificity (area under the curve 0.788).
Conclusion The existing clinical criteria have good specificity in identifying mutation carriers. However, their sensitivity is too low for clinical use. Analysis of QTc duration alone is more useful to screen for LQTS carriership (QTc
430 ms) as its sensitivity is far superior, although its specificity remains acceptable. In genotyped families, genetic testing is the preferred diagnostic test.
Key Words: Long QT syndrome Ventricular arrhythmias Molecular genetics Diagnostic criteria
![]()
CiteULike
Connotea
Del.icio.us What's this?
Related articles in EHJ:
- Clinical diagnosis of long QT syndrome: back to the caliper
- Tom Rossenbacker and Silvia G. Priori
EHJ 2007 28: 527-528.[Extract] [Full Text]
This article has been cited by other articles:
![]() |
F. R Breijo-Marquez and M. P. Rios Variability and diversity of the electrical cardiac systole BMJ Case Reports, March 17, 2009; 2009(mar08_1): bcr0620080284 - bcr0620080284. [Abstract] [Full Text] |
||||
![]() |
K. H. Haugaa, T. Edvardsen, T. P. Leren, J. M. Gran, O. A. Smiseth, and J. P. Amlie Left ventricular mechanical dispersion by tissue Doppler imaging: a novel approach for identifying high-risk individuals with long QT syndrome Eur. Heart J., February 1, 2009; 30(3): 330 - 337. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. I. Berul Congenital Long-QT Syndromes: Who's at Risk for Sudden Cardiac Death? Circulation, April 29, 2008; 117(17): 2178 - 2180. [Full Text] [PDF] |
||||
![]() |
D. M. Roden Long-QT Syndrome N. Engl. J. Med., January 10, 2008; 358(2): 169 - 176. [Full Text] [PDF] |
||||
![]() |
H. L. Tan, J. P.P. Smits, A. Loef, M. W.T. Tanck, M. Hardziyenka, and M. E. Campian Electrocardiographic evidence of ventricular repolarization remodelling during atrial fibrillation Europace, January 1, 2008; 10(1): 99 - 104. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Hofman, A. A. M. Wilde, and H. L. Tan Diagnostic criteria for congenital long QT syndrome in the era of molecular genetics: do we need a scoring system? Eur. Heart J., June 1, 2007; 28(11): 1399 - 1399. [Full Text] [PDF] |
||||




